{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:28:42Z","timestamp":1793672922595,"version":"4.5.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","award":["17-0100"],"award-info":[{"award-number":["17-0100"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xphs.2024.10.023","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T13:07:54Z","timestamp":1730552874000},"page":"458-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of surfactants on solution behavior and membrane transport of amorphous solid dispersions"],"prefix":"10.1016","volume":"114","author":[{"given":"Amjad","family":"Alhalaweh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira El","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-2612","authenticated-orcid":false,"given":"Christel A.S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2024.10.023_bib0001","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-014-0156-1","article-title":"Preclinical formulations : insight, strategies, and practical considerations","volume":"15","author":"Shah","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.023_bib0002","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jps.23146","article-title":"Materials science tetrahedron\u2014a useful tool for pharmaceutical research and development","volume":"101","author":"Psimadas","year":"2012","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.023_bib0003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/17425255.2.5.715","article-title":"Preclinical formulations for discovery and toxicology: physicochemical challenges","volume":"2","author":"Neervannan","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.023_bib0004","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1021\/acs.molpharmaceut.8b00699","article-title":"Impact of drug physicochemical properties on lipolysis-triggered drug supersaturation and precipitation from lipid-based formulations","volume":"15","author":"Alsk\u00e4r","year":"2018","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.10.023_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejps.2005.11.012","article-title":"Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents","volume":"28","author":"Kawakami","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.023_bib0006","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/js980433o","article-title":"Solubilization of ionized and un-ionized flavopiridol by ethanol and polysorbate 20","volume":"88","author":"Li","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.023_bib0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2016.03.006","article-title":"Physical chemistry of supersaturated solutions and implications for oral absorption","volume":"101","author":"Taylor","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2024.10.023_bib0008","doi-asserted-by":"crossref","unstructured":"Newman A.W., Childs S.L., Cowans B.A. Salt and cocrystal form selection. Preclinical Development Handbook: ADME and Biopharmaceutical Properties. Published online 2008:455\u2013481. doi:10.1002\/9780470249031.ch14","DOI":"10.1002\/9780470249031.ch14"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.023_bib0009","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/cg801039j","article-title":"Solubility advantage of pharmaceutical cocrystals","volume":"9","author":"Good","year":"2009","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.023_bib0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/cg4015256","article-title":"Effects of polymer and surfactant on the dissolution and transformation profiles of cocrystals in aqueous media","volume":"14","author":"Alhalaweh","year":"2014","journal-title":"Cryst Growth Des"},{"issue":"May","key":"10.1016\/j.xphs.2024.10.023_bib0011","article-title":"Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products","volume":"586","author":"Pandi","year":"2020","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.023_bib0012","first-page":"799","article-title":"Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures","volume":"12","author":"Hancock","year":"1995","journal-title":"Pharm Res Off J Am Assoc Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.023_bib0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2017.04.015","article-title":"Mechanism-based selection of stabilization strategy for amorphous formulations : insights into crystallization pathways","volume":"256","author":"Edueng","year":"2017","journal-title":"J Control Rel"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.023_bib0014","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1021\/acs.molpharmaceut.0c00835","article-title":"Insights into dissolution and solution chemistry of multidrug formulations of antihypertensive drugs","volume":"17","author":"El Sayed","year":"2020","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2024.10.023_bib0015","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1021\/acs.molpharmaceut.1c00480","article-title":"Impact of simulated intestinal fluids on dissolution, solution chemistry, and membrane transport of amorphous multidrug formulations","volume":"18","author":"El Sayed","year":"2021","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.023_bib0016","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/cg301679h","article-title":"Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: implications for solubility enhancing formulations","volume":"13","author":"Ilevbare","year":"2013","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.023_bib0017","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp500573z","article-title":"Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir","volume":"12","author":"Mosquera-Giraldo","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.023_bib0018","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/mp500571m","article-title":"Assessment of the amorphous \u201c solubility \u201d of a group of diverse drugs using new experimental and theoretical approaches","volume":"12","author":"Almeida","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.023_bib0019","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s11095-017-2144-0","article-title":"Impact of micellar surfactant on supersaturation and insight into solubilization mechanisms in supersaturated solutions of Atazanavir","volume":"34","author":"Indulkar","year":"2017","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.023_bib0020","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/cg301679h","article-title":"Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: implications for solubility enhancing formulations","volume":"13","author":"Ilevbare","year":"2013","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.023_bib0021","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/mp5006245","article-title":"Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.023_bib0022","article-title":"Interplay of supersaturation and solubilization: lack of correlation between concentration-based supersaturation measurements and membrane transport rates in simulated and aspirated human fluids","author":"Elkhabaz","year":"2019","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.023_bib0023","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s11095-017-2144-0","article-title":"Impact of micellar surfactant on supersaturation and insight into solubilization mechanisms in supersaturated solutions of Atazanavir","volume":"34","author":"Indulkar","year":"2017","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.023_bib0024","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.xphs.2019.04.006","article-title":"Effect of amorphous nanoparticle size on bioavailability of anacetrapib in dogs","volume":"108","author":"Kesisoglou","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.023_bib0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1023\/A:1007581202873","article-title":"Mechanistic studies on surfactant-induced membrane permeability enhancement","volume":"17","author":"Xia","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.023_bib0026","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.023_bib0027","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.023_bib0028","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1023\/A:1010974909998","article-title":"Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells","volume":"18","author":"Behrens","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.023_bib0029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.addr.2012.09.005","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"64","author":"Artursson","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2024.10.023_bib0030","unstructured":"A.G. Huesgen. Agilent Application Note: determination of Log P for Compounds of Different Polarity the Agilent 1200 Infinity Series Impurity Analyzer System.; 2019."},{"issue":"1","key":"10.1016\/j.xphs.2024.10.023_bib0031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/10717544.2019.1704940","article-title":"Mechanisms of increased bioavailability through amorphous solid dispersions: a review","volume":"27","author":"Schittny","year":"2020","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.023_bib0032","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11095-009-0021-1","article-title":"Understanding the behavior of amorphous pharmaceutical systems during dissolution","volume":"27","author":"Alonzo","year":"2010","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.023_bib0033","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/mp050004g","article-title":"Role of molecular interaction in stability of celecoxib-PVP amorphous systems","volume":"2","author":"Gupta","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.023_bib0034","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/03639040701744020","volume":"34","author":"Miyako","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.023_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jps.20500","article-title":"Solubilization of two structurally related anticancer drugs: XK-469 and PPA","volume":"95","author":"He","year":"2006","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.023_bib0036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2013.11.001","article-title":"Fundamental aspects of solid dispersion technology for poorly soluble drugs","volume":"4","author":"Huang","year":"2014","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.023_bib0037","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/cg4015256","article-title":"Effects of polymer and surfactant on the dissolution and transformation profiles of cocrystals in aqueous media","volume":"14","author":"Alhalaweh","year":"2014","journal-title":"Cryst Growth Des"},{"issue":"5","key":"10.1016\/j.xphs.2024.10.023_bib0038","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/cg801039j","article-title":"Solubility advantage of pharmaceutical cocrystals","volume":"9","author":"Good","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2024.10.023_bib0039","article-title":"Polymer type impacts amorphous solubility and drug-rich phase colloidal stability: a mechanistic study using nuclear magnetic resonance spectroscopy","author":"Ueda","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.023_bib0040","first-page":"1","article-title":"Impact of hypromellose acetate succinate grade on drug amorphous solubility and in vitro membrane transport","author":"Ueda","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.023_bib0041","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2018.04.014","article-title":"Tailoring supersaturation from amorphous solid dispersions","volume":"279","author":"Li","year":"2018","journal-title":"J Control Rel"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.023_bib0042","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.xphs.2017.09.024","article-title":"Coamorphous active pharmaceutical ingredient\u2013small molecule mixtures: considerations in the choice of coformers for enhancing dissolution and oral bioavailability","volume":"107","author":"Newman","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.10.023_bib0043","doi-asserted-by":"crossref","unstructured":"Mullin J.W. Solutions and solubility. Crystallization. 2001;(2001):86\u2013134. doi:10.1016\/b978-075064833-2\/50005-x","DOI":"10.1016\/B978-075064833-2\/50005-X"},{"key":"10.1016\/j.xphs.2024.10.023_bib0044","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2020.12.018","article-title":"Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size","volume":"330","author":"Ueda","year":"2021","journal-title":"J Control Rel"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:36:13Z","timestamp":1734726973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924004702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022354924004702"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of surfactants on solution behavior and membrane transport of amorphous solid dispersions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}